Le Lézard

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...
Irish ExaminerOpinion

Colman Noctor: Understanding science starts with moments of shared wonder, not in our genes

I’ve lost count of how many times I’ve heard parents say, “She’s just not a maths person”. We don’t say, “He’s not a reading ...

Don’t dismiss kids’ sadness or anger. How to minimise family conflict over the social media ban

If you have a child or teen under 16 who loves their social media accounts, how can you help approach the new restrictions ...
Harvard Graduate School of EducationOpinion

When Kids Feel They Matter, They Do Better in Life

We know that children need the basics — nutritious food, clean air, and safe places to learn and live. But to really thrive, ...